Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

21.51 -0.25 (-1.15%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	926,012
Open	21.74
Bid (Size)	18.05 (900)
Ask (Size)	21.77 (500)
Prev. Close	21.76
Today's Range	21.25 - 21.98
52wk Range	8.800 - 32.71
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors with Losses to Contact the Firm Before November 3, 2026

Today 11:15 EDT

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

Today 10:37 EDT

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Performance

YTD	-26.5%	-26.5%
1 Month	+11.2%	+11.2%
3 Month	+35.2%	+35.2%
6 Month	+86.7%	+86.7%
1 Year	-5.4%	-5.4%

More News

Kaplan Fox & Kilsheimer LLP Reminds Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX) and Lead Plaintiff Deadline on November 3, 2026

September 24, 2026

Via NewMediaWire

Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX

September 24, 2026

From SkyMedia, LLC

Via GlobeNewswire

Kaplan Fox Class Action Reminder: Beta Bionics, Inc. (NASDAQ: BBNX) Lead Plaintiff Deadline is November 3, 2026

September 24, 2026

Via NewMediaWire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. (BBNX)

September 24, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Beta Bionics, Inc. (NASDAQ: BBNX) is November 3, 2026

September 23, 2026

Via NewMediaWire

Kaplan Fox Alerts Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Pending Securities Class Action – Deadline is November 3, 2026

September 23, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Kaplan Fox Deadline Alert: Beta Bionics, Inc. (NASDAQ: BBNX) Investors Have Until November 3, 2026 to Seek a Lead Plaintiff Role

September 22, 2026

Via NewMediaWire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX

September 22, 2026

From Pomerantz LLP

Via GlobeNewswire

Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

September 22, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Beta Bionics, Inc. Investors of Upcoming Deadline

September 22, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Kaplan Fox Urges Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Deadline on November 3, 2026

September 22, 2026

Via NewMediaWire

BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

September 22, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Beta Bionics, Inc. (NASDAQ: BBNX); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is

September 22, 2026

From Grabar Law Office

Via GlobeNewswire

Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365

September 22, 2026

From Beta Bionics, Inc.

Via GlobeNewswire

Kaplan Fox Announces a Securities Class Action Filed Against Beta Bionics, Inc. (NASDAQ: BBNX) - Lead Plaintiff Deadline is November 3, 2026

September 21, 2026

Via NewMediaWire

Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Securities Class Action Deadline on November 3, 2026

September 21, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Kaplan Fox Continues to Remind Beta Bionics, Inc. (NASDAQ: BBNX) Investors of the Lead Plaintiff Deadline on November 3, 2026

September 18, 2026

Via NewMediaWire

Robbins LLP Urges BBNX Stockholders Who Lost Money Investing in Beta Bionics, Inc. to Contact the Firm for Information About Leading the Class Action

September 18, 2026

From Robbins LLP

Via Business Wire

Kaplan Fox Urges Investors of Beta Bionics, Inc. (NASDAQ: BBNX) with Significant Losses to Seek a Leadership Role Before November 3, 2026

September 18, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on November 3, 2026 Against Beta Bionics, Inc. (NASDAQ: BBNX)

September 17, 2026

Via NewMediaWire

Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock

September 17, 2026

From Beta Bionics, Inc.

Via GlobeNewswire

Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX

September 17, 2026

From SkyMedia, LLC

Via GlobeNewswire

Kaplan Fox Continues to Alert Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Class Action Deadline on November 3, 2026

September 17, 2026

Via NewMediaWire

Frequently Asked Questions

Is Beta Bionics, Inc. - Common Stock publicly traded?

Yes, Beta Bionics, Inc. - Common Stock is publicly traded.

What exchange does Beta Bionics, Inc. - Common Stock trade on?

Beta Bionics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Beta Bionics, Inc. - Common Stock?

The ticker symbol for Beta Bionics, Inc. - Common Stock is BBNX on the Nasdaq Stock Market

What is the current price of Beta Bionics, Inc. - Common Stock?

The current price of Beta Bionics, Inc. - Common Stock is 21.51

When was Beta Bionics, Inc. - Common Stock last traded?

The last trade of Beta Bionics, Inc. - Common Stock was at 09/25/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.